Ascendis Pharma A/S (ASND)
NASDAQ
Closed
Oct 6, 2026
Day's Range
222.7252 wk Range
186.05Profile - ASND - Ascendis Pharma A/S
Profile
Mic Code
XNGS
Sector
Healthcare
Industry
Biotechnology
Employees
1.18K
Ascendis Pharma A/S is a global biopharmaceutical company focused on developing and commercializing therapies for rare endocrine diseases and other serious chronic conditions. The company uses its proprietary TransCon technology platform to create medicines designed to improve treatment delivery and address unmet medical needs. Its current portfolio includes marketed products for growth hormone deficiency and chronic hypoparathyroidism, along with clinical-stage programs in endocrinology rare disease and oncology. Headquartered in Copenhagen, Denmark, Ascendis Pharma operates across Europe and the United States, combining research, development, and commercialization capabilities to support patients, physicians, and healthcare systems in specialized therapeutic areas.
Profile Details
Type
Common Stock
Address
Tuborg Boulevard 12
City
Hellerup
Zip
2900
Country
Denmark
Phone
45 70 22 22 44
Key Executives - ASND - Ascendis Pharma A/S
Key executives
Cross Listings - ASND - Ascendis Pharma A/S
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
